Artesunate, the active agent from Artemisia annua L. used in the traditional Chinese medicine, is being applied as first-line drug for malaria treatment, and trials are ongoing that include this drug in cancer therapy. Despite increasing interest in its therapeutic application, the mode of cell kill provoked by artesunate in human cells is unknown. Here, we show that artesunate is a powerful inducer of oxidative DNA damage, giving rise to FPG-sensitive sites and the formation of 8-oxo-guanine and 1,N6-ethenoadenine. Oxidative DNA damage was induced in LN-229 human glioblastoma cells dose dependently and was paralleled by cell death executed by apoptosis and necrosis, which could be attenuated by radical scavengers such as Nacetyl cysteine. Oxidative DNA damage resulted in DNA double-strand breaks (DSB) as determined by γH2AX foci that co-localized with 53BP1. Upon chronic treatment with artesunate, the level of DSB continuously increased over the treatment period up to a steady-state level, which is in contrast to ionizing radiation that induced a burst of DSB followed by a decline due to their repair. Knockdown of Rad51 by siRNA and inactivation of DNA-PK strongly sensitized glioma cells to artesunate. The data indicate that both homologous recombination and non-homologous end-joining are involved in the repair of artesunate-induced DSB. Artesunate provoked a DNA damage response (DDR) with phosphorylation of ATM, ATR, Chk1 and Chk2.
Introduction
The natural compound artemisinin, derived from Artemisia annua L., which has been used for centuries in the traditional Chinese medicine (TCM), and its semi-synthetic derivatives artesunate ( Fig. 1 ) and artemether are anti-malaria drugs that also exert remarkable anti-cancer activity in vitro and in vivo [1] [2] [3] . The active chemical moiety of artemisinin-type compounds is an endoperoxide bridge, which is cleaved in the presence of ferrous iron by a Fenton-type reaction. This leads, in plasmodia, to the generation of reactive oxygen species (ROS), e.g. hydroxyl radicals and superoxide anions [4] as well as carbon-centered radical molecules [5] . In plasmodia, these reactive species were shown to alkylate proteins [5] [6] [7] , which is thought to be the underlying reason of the bacteriostatic effect. Since ferrous iron is present in high amounts in erythrocytes bearing plasmodium parasites and in cancer cells, the activity towards malaria infections and cancer cells might be explained by the same biochemical mechanism. Indeed, exogenous application of iron to cancer cells in the form of transferrin or the drug Ferrosanol ® increased the activity of artesunate [8, 9] .
Furthermore, oxidative stress response genes are determinants for artesunate resistance [8, 9] .
While the present model claims that protein alkylation is the cause for artesunate induced toxicity [10] , we have recently shown that artesunate is able to induce DNA damage, which is repaired by specific repair pathways [11] . The molecular nature of the DNA damage induced by artesunate has not yet been identified. Since artesunate gives rise in a Fenton-type reaction to ROS, it is tempting to hypothesize that artesunate-induced ROS formation may lead to oxidative DNA damage, which ultimately accounts for the cytotoxic activity observed in cancer cells. To prove this hypothesis, we measured the formation of 8-oxoguanine (8-oxoG) and 1,N6-etheno adenine (ethenoA), which are main oxidative DNA lesions, following treatment of LN-229 human glioblastoma cells with artesunate. Oxidative DNA damage, induction of DNA double-strand breaks (DSB), DNA damage signaling and apoptosis/necrosis were observed to be induced, indicating that artesunate acts as a potential genotoxic anticancer drug. The role of oxidative DNA damage was confirmed by ROS scavengers, e.g. N-acetyl cysteine, which reversed the detrimental effects of artesunate on LN-229 cells. Hence, we were able to identify for the first time critical oxidative DNA lesions induced by artesunate in human cells that activate cell death 4 mechanisms and thus cause cancer cell death. We also show that artesunate induces during the treatment period a sustained level of oxidative DNA lesions and DSB, which is different from ionizing radiation, and that DSB repair strongly contributes to resistance of glioma cells to artesunate.
Material and Methods

Cell culture and drug treatment
For the experiments we used the cell line LN-229, which is a human glioblastoma line wild-type for p53 [12] . The line was kindly provided by Dr. Weller (Tübingen, Germany) and used and described in our previous work [13, 14] . LN-229 cells were stably transfected with shRNA targeting Rad51 or with the empty vector. Selection occurred with G418 as previously described [15] . We also used the cell lines MO59K
and MO59J, which are isogenic human glioblastoma lines wild-type for p53, but proficient and deficient in DNA-PK CS respectively [16] . The lines were a kind gift of Dr. M. Rave-Fränk (Göttingen, Germany) and described previously [15] . Cells were cultured in DMEM/high glucose medium supplemented with 5 % FCS at 7 % CO 2 and 37° C. They were cultured for a maximal period of three month and then replaced by a new batch. They were checked routinely for mycoplasma contamination. Artesunate (Dafra Pharma, Turnhout, Belgium) was prepared by dissolving the drug in dimethyl sulphoxide (DMSO) and diluting it in sterile phosphate buffered saline (PBS) to a final concentration of 2 mg/ml. Stock solution was aliquoted and stored at -20° C until use. Iron(II)-glycine sulfate (Ferrosanol) was obtained from Sanol (Monheim, Germany) and used at a concentration of 10 µg/ml. tbutyl hydroperoxide (BOOH) was from Sigma (Germany) and diluted in PBS.
Determination of apoptosis and necrosis
The apoptotic frequency was determined by SubG1 fraction or annexin V/propidium iodide double-staining quantified by flow cytometry using a FACS Calibur as previously described [17] . The number of apoptotic cells and the cell populations were calculated using the CellQuestPro program of Beckdon Dickinson (BD, Heidelberg, Germany).
Determination of ROS formation
To evaluate ROS production following artesunate treatment, the membrane permeable indicator H 2 DCFDA was employed. Cells were pre-incubated with 10 µM H 2 DCFDA in serum-free medium at 37 °C for 30 min and thereafter treated with artesunate. After different times, cells were washed twice with PBS and monitored with a FACS Calibur (BD, Heidelberg, Germany) at an excitation wavelength of 488 nm and an emission wavelength of 525 nm. The ROS level was determined by comparing the changes in fluorescence intensity with that of the control.
Single cell gel electrophoresis (comet assay)
Exponentially growing cells were exposed to artesunate and after different time periods trypsinized and washed with ice-cold PBS. Alkaline cell lysis and electrophoresis was essentially performed as described previously [18] .
Formamidopyrimidine-DNA glycosylase (FPG) (generous gift from Bernd Epe, Mainz) was added to the agarose gel on the slide at a dilution of 1 mg/ml. The slides were incubated for 45 min at 37°C. Electrophoresis (23 V) was performed at 4°C for 15 min in 90 mmol/L Tris, 90 mmol/L boric acid, and 2 mmol/L EDTA (pH 7.5).
Propidium iodide stained slides were evaluated using a fluorescence microscope and the Komet 4.0.2 software from Kinetic Imaging Ltd. (Liverpool, UK). Data were expressed as Tail Moment (TM), which represents the percentage of DNA in the tail multiplied by the length between the centre of the head and tail [19] . were fixed with methanol:acetone (7:3) for 7 min at -20° C and rehydrated in PBS.
Phospho-H2AX and 53BP1 immunofluorescence staining
After treatment with RNAse A (200 µg/ml in PBS) and RNAse T1 (50 units/ml in PBS) for 1 h at 37° C, cover slips were washed in PBS. DNA was denatured by incubation in a solution containing 70 mM NaOH, 0.14 M NaCl and 40 % methanol for 5 min at 0° C. For proteolysis cells were incubated with PBS containing 0.1 % trypsine for 
Image Analysis
Fluorescence images were recorded and quantified using a laser scanning microscope (LSM 710) and the ZEN Software from Carl Zeiss AG (Jena, Germany).
Each value represents the average fluorescence intensity of at least 50 nuclei.
Preparation of protein extracts and western blot analysis
Whole cell extracts were prepared by lysis of the cells on the plates in 95° C % duty cycle) homogenates were stored at -20° C. Western blot analysis was performed as previously described [20] . Protein-antibody complexes were visualized by ECL (Amersham). Antibodies were purchased from Amersham Biosciences AB, Millipore GmbH, Calbiochem, Merck Chemicals Ltd., and Cell Signalling Technology.
Statistics
Experiments were conducted at least three times. Values were compared statistically using the unpaired T test. Significance levels: * p<0.05; ** p<0.005; *** p<0.001.
Results
Artesunate induces apoptosis and necrosis in human glioma cells
Experiments were performed with LN-229 human glioblastoma cells, which are wildtype for p53 [14] . In previous studies we showed that these cells are repair competent and undergo apoptosis upon genotoxic anticancer drug treatment [15] .
Following artesunate exposure, LN-229 cells undergo apoptosis dose-dependently.
In the range of 5-50 µg/ml (chronic exposure) artesunate induces apoptosis, as determined by subG1 fraction (Fig. 1B) . Using annexin V/PI double-staining, we quantified the level of apoptosis and necrosis and observed that artesunate also induces a considerable amount of necrosis (Fig. 1C) . Cell death by apoptosis is a late response that starts two days after the onset of treatment and remains at a high level for at least 5 days (Fig. 1D ). The addition of ferrosanol to the medium significantly ameliorated the frequency of apoptosis and necrosis ( Fig. 1E ), supporting the paradigm that a Fenton-type reaction that gives rise to ROS formation is involved in artesunate activation in cancer cells.
Artesunate induces oxidative DNA damage
To elucidate the role of ROS in artesunate-induced cell death we determined the intracellular ROS level by CH2-staining ( Fig. 2A for a representative example).
Intracellular ROS clearly increased with artesunate exposure time, reaching a level after 24 h exposure (15 µg/ml) that even exceeded the level induced by t-butyl hydroperoxide (BOOH), which is a powerful oxidative genotoxin (Fig. 2B ). Intracellular ROS is thought to damage the nuclear DNA. Therefore, we determined the level of 8-oxoguanine (8-oxoG), which is the major DNA oxidation product. We utilized a modified alkaline comet assay, which is based on treatment of lysed cells with formamidopyrimidine-DNA glycosylase (FPG) protein prior to electrophoresis.
FPG is a bacterial damage-specific DNA glycosylase that recognizes 8-oxoG, and by removing the base, FPG generates apurinic sites that are converted to single-strand breaks (SSB) under the alkaline conditions of the assay. As shown in Fig. 2C , without FPG no SSB were induced whereas in the presence of FPG SSB were induced that increased significantly as a function of artesunate dose. These breaks were not immediately induced at significant amounts. They were first detected 6 h after the addition of artesunate to the medium and later on remained at a high level (Fig. 2D) , which indicates that DNA base damage formation by artesunate is a slow process, not comparable to direct oxidizing agents such as BOOH, for which 8-oxoG formation can be observed immediately after treatment (Fig. 3A) .
To confirm this data, we determined the 8-oxoG levels by immunocytochemistry. As Another biologically relevant DNA oxidation product is 1,N6-ethenoadenine (ethenoA). Since ethenoA is supposed to be a replication blocking DNA adduct [21] and, therefore, a presumptive cytotoxic DNA lesion [22] , we wondered whether (Fig. 4A) . Quantification revealed that after 6 h the level was significantly enhanced and 24 h following treatment an ethenoA level similar to a toxic dose (400 mM) of BOOH was reached (Fig. 4B) . The finding substantiates that artesunate generates a sustained ROS level that continuously induces oxidative DNA damage and that this damage accumulates over the treatment period.
If artesunate generates DNA damaging ROS in mammalian cells, it is anticipated that ROS scavengers are able to reduce the level of DNA damage. This was indeed the case as curcumin, resveratrol and N-acetyl cysteine, all of which have radical scavenging properties [23] [24] [25] [26] , completely prevented artesunate mediated 8-oxoG formation (Fig. 4C) . Furthermore, the ROS scavenger N-acetyl cysteine greatly reduced the killing effect of artesunate in LN-229 cells (Fig. 4D) , indicating that artesunate-induced oxidative DNA damage is responsible for the killing effect of the drug.
Artesunate induces a sustained-increasing level of DNA double-strand breaks, which is different from ionizing radiation
The most severe lethal lesions produced by ROS are DSB [27] , which are powerful inducer of apoptosis [28] . To elucidate whether artesunate is able to induce DSB, we determined the phosphorylation level of histone 2AX (γH2AX). As shown in Fig. 5A , H2AX phosphorylation at ser139 occurred already 2 h after the onset of artesunate treatment, increased with time 6 h later and remained at this high level up to 24 h following treatment. We also determined γH2AX foci by immunocytochemistry ( Fig.   5B for a representative example and 5C for quantification), which is a widely accepted marker for DSB [29, 30] . As shown in a dose-dependent experiment in Fig.   5D , artesunate induces γH2AX foci in LN-229 cells that increased nearly linearly with exposure time, which is in stark contrast to ionizing radiation (IR) for which γH2AX foci reached a maximum 1 h after treatment and thereafter declined (Fig. 5D ) as a result of DSB repair [31] . In artesunate exposed cells, a maximum level was induced at 10 h that did not increase further when the exposure time was extended to 24 h (Fig. 5D) , which is conform with the hypothesis that DSB are formed and repaired 
leading finally to an equilibrium level. γH2AX foci co-localized with 53BP1 ( Fig. 5E for a representative example and Fig. 5F for quantification), which is a strong additional indication for the ability of artesunate to induce "true" DSB.
Both HR and NHEJ protect against artesunate-induced cell death
Previously, we reported that mutant Chinese hamster cells impaired in the homologous recombination (HR) pathway of DSB repair are hypersensitive to artesunate [11] . This finding prompted us to translate the finding to cancer cells and determined whether down-regulation of HR in glioma LN-229 cells impacts their killing response following artesunate treatment. To this end we stably transfected LN-229 cells with a Rad51 shRNA vector, which clearly down-regulates Rad51 protein expression (Fig. 6A, insert) . Treatment of these cells with artesunate led to a dramatic increase in the level of apoptosis, as compared to empty vector transfected cells (Fig. 6A) . The data substantiate the finding that the HR repair pathway is involved in protection against artesunate-induced genotoxicity.
Is non-homologous end-joining (NHEJ) involved in DSB repair following artesunate treatment as well? To this end we assessed the killing response of a pair of glioma cells wild-type (MO59K) and mutated for DNA-PK CS (MO59J). MO59K cells were highly resistant to artesunate and underwent cell death (executed mostly by necrosis) only at the high dose level of 50 µg/ml (Fig. 6B) . In contrast, MO59J cells were more sensitive, undergoing death already at 10 µg/ml artesunate (Fig. 6C) . In these cells death was executed mostly by apoptosis and less by necrosis (compare Fig. 6B and C). To substantiate that NHEJ is involved in protection against artesunate, we treated p53wt glioma cells (LN-229) with a DNA-PK CS inhibitor (NU7026). Inhibition of DNA-PK CS , which is a main component of NHEJ, greatly sensitized glioma cells to artesunate (Fig. 6D, compare with Fig. 1C ). Similar to MO59K cells, a large amount of necrosis was induced (Fig. 6D) . This necrosis induction is related to ATP depletion, which is currently under study (data not shown). The data suggests that NHEJ, together with HR, is involved in the defense against artesunate-induced DNA damage. 
Discussion
This study was conducted to provide evidence that artesunate, which is a widely used drug for the treatment of malaria, is able to induce oxidative DNA damage in mammalian cells. We utilized a glioma cell line (LN-229) for the study because the mechanism of death in glioma cells following DNA damage has been well established in our previous work [13] [14] [15] . Here we show for the first time that artesunate is able to induce oxidative DNA damage, i.e. 8-oxoG and ethenoA, which are two main oxidative DNA base adducts. We should note that 8-oxoG is a mispairing lesion that is considered to be responsible for the induction of point mutations following ROS [32] [33] [34] . This points to the possibility that artesunate bears a mutagenic potential, which should be considered a side effect of its use as an anti-malaria drug. EthenoA is likely a replication-blocking lesion [21, 22] that, if not repaired in time, may cause stalled DNA replication that ends up with DSB formation and activation of the DNA damage response. This was indeed observed in LN-229 glioma cells. Our observation that down-regulation of HR (by siRad51) greatly ameliorates the killing effect of artesunate is compatible with the model that stalled and finally collapsed replication forks yield the formation of DSB that finally trigger apoptosis [35] .
Artesunate-induced ROS may also produce DSB directly. This minor fraction is, similar to ionizing radiation [36] , likely to be subject to NHEJ, which explains why level is reached. This is in contrast to the well-known effect of ionizing radiation that induces a burst of DSB immediately after irradiation (Fig. 5D and ref. [37] ).
Interestingly, the frequency of DSB (as determined by phosphorylation of ser139 of H2AX) following artesunate increased with time after exposure reaching a plateau, which is explained by the equilibrium between the formation and repair of DNA lesions. Thus, although artesunate is a ROS producer, it differs significantly from ionizing radiation and chemical oxidative agents in their ability to produce a sustained level of oxidative DNA lesions, including DSB. Chronic and sustained formation of low-level DNA adducts and DSB that accumulate in the treatment period is not achieved by acute radiation and chemical direct oxidizing agents. We hypothesize that the sustained formation of DNA oxidation products, notably DSB, following artesunate may differ in their biological consequences from lesions that are formed in a pulse-wise manner being, if generated above a particular threshold, an activator of death signaling, which is tolerated in normal but not tumor cells.
Another reasonable supposition for tumor specificity of the killing effect of artesunate In our experiments, we observed DSB formation and activation of DDR within the artesunate treatment period much earlier than the onset of apoptosis. This lag phase between the induction of critical lesions and apoptosis execution is also known from other experimental systems and genotoxic exposures [15, 28] . It is tempting to speculate that critical components of the cell death pathway need to become accumulated until the pathway can be fully activated. We should also note that compared to other genotoxic anticancer drugs such as temozolomide artesunate induces a comparatively high level of necrosis. This could be the consequence of extensive base damage that activates base excision repair, which in turn leads to 
